Nuremberg, Germany

Kurt-Henning Ahrens


Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 1990-1993

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Kurt-Henning Ahrens

Introduction

Kurt-Henning Ahrens, based in Nuremberg, Germany, is a notable inventor in the pharmaceutical field with four patents to his name. His work primarily focuses on developing new compounds for the treatment of heart and circulatory diseases, showcasing a commitment to improving healthcare outcomes.

Latest Patents

Ahrens has recently contributed to the advancement of pharmaceutical compositions with two significant patents. The first patent involves an imidazolyl propyl guanidine derivative, which is characterized by advantageous properties specifically for treating heart and circulatory diseases. This innovation represents a step forward in cardiology, aiming to enhance the efficacy of therapies available to patients suffering from cardiovascular issues.

The second patent details new cardiotonic thiadiazine derivatives that provide more selective action compared to existing compounds. These compounds, according to Ahrens' findings, serve as new positive inotropic agents that can offer improved treatment and prevention options for heart and circulation-related ailments.

Career Highlights

Kurt-Henning Ahrens is a distinguished inventor associated with Heumann Pharma GmbH & Co. His career has been marked by significant contributions to pharmaceutical research, particularly in synthesizing derivatives that offer enhanced therapeutic effects. Ahrens’ innovations draw from extensive research and a deep understanding of medicinal chemistry, aiming to address pressing health concerns.

Collaborations

Throughout his career, Ahrens has collaborated with esteemed colleagues, including Peter Morsdorf and Heidrun Engler. These partnerships have facilitated a dynamic exchange of ideas and expertise, leading to groundbreaking developments in pharmaceutical research and innovation. Working alongside such talented individuals has enriched Ahrens’ contributions to the field.

Conclusion

Kurt-Henning Ahrens' work exemplifies the spirit of innovation in the pharmaceutical industry. With a focus on developing new compounds to tackle heart and circulatory diseases, Ahrens continues to make significant strides in enhancing healthcare solutions. His dedication to research and collaboration underscores the importance of inventors in driving medical advancements forward.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…